UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
| | Commission File Number: | 001-37847 |
MOTIF BIO PLC
(Exact name of registrant as specified in its charter)
125 Park Avenue
25th Floor
New York, New York 10017
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
American Depositary Shares each representing 20 Ordinary Shares
Ordinary Shares, par value £0.01 per share not for trading, but only in connection with the registration of the American Depositary Shares)
Warrants to purchase American Depositary Shares each representing 20 Ordinary Shares
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| | Rule 12g-4(a)(1) | ☐ | | | | |
| | Rule 12g-4(a)(2) | ☐ | | | | |
| | Rule 12h-3(b)(1)(i) | ☐ | | | | |
| | Rule 12h-3(b)(1)(ii) | ☐ | | | | |
| | Rule 15d-6 | ☒ | | | | |
| | Rule 15d-22(b) | ☐ | | | | |
Approximate number of holders of record as of the certification or notice date: 230
Approximate number of holders of record as of January 1, 2020: 223
Pursuant to the requirements of the Securities Exchange Act of 1934, Motif Bio plc has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: | March 26, 2020 | | | MOTIF BIO PLC | |
| | | | | | |
| | | | By: | /s/ Graham Lumsden | |
| | | | Name: | Graham Lumsden | |
| | | | Title: | Chief Executive Officer | |
